Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Gary A. Cain"'
Autor:
Jennifer Epler, Joachim Rudolph, Joy Drobnick, Roxanne Vega, Ignacio Aliagas, Sreemathy Ramaswamy, Elizabeth Blackwood, Klaus P. Hoeflich, Diana Jakubiak, Wendy Lee, Haiming Zhang, Xianrui Zhao, Weiru Wang, Christopher E. Heise, David Favor, Chudi Ndubaku, Thomas W. O'Brien, Gary A. Cain, Lesley J. Murray, Paroma Chakravarty, Hank La, Christy C. Ong, Ping Dong, Connie Chan, James J. Crawford, Angela Oh, Yu Zhong, Dolores Díaz, Lewis J. Gazzard
Publikováno v:
Journal of medicinal chemistry. 59(11)
p21-activated kinase 1 (PAK1) has an important role in transducing signals in several oncogenic pathways. The concept of inhibiting this kinase has garnered significant interest over the past decade, particularly for targeting cancers associated with
Autor:
Melissa Estrella, Christopher A. Teleha, Gary A. Cain, Alfred J. Mical, Andrew M. Blum, Edd R. Holler, James S. Piecara, George C. Emmett, Dean A. Wacker
Publikováno v:
Synthesis. 2005:92-96
Methods for the preparation of (3S)-3-(4-fluorobenzyl)piperidine (2) and its mandelate salt (9) are described. The first generation synthesis started from 3-benzylpiperidone, and required Boc protection of the nitrogen for efficient separation of the
Autor:
Gary M. Cain
Publikováno v:
Compensation & Benefits Review. 35:36-42
Autor:
Argyrios G, Arvanitis, Joseph T, Rescinito, Charles R, Arnold, Richard G, Wilde, Gary A, Cain, Jung Hui, Sun, Jia-Sheng, Yan, Christopher A, Teleha, Lawrence W, Fitzgerald, John, McElroy, Robert, Zaczek, Paul R, Hartig, Scott, Grossman, Stephen P, Arneric, Paul J, Gilligan, Richard E, Olson, David W, Robertson
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:125-128
A series of high affinity CRF receptor ligands with an imidazo[4,5-b]pyridine core is described. Individual analogues were synthesized and tested in a rat CRF receptor binding assay. The best compounds were further tested in the dog N-in-1 pharmacoki
Autor:
Gary A. Cain, Spencer Drummond
Publikováno v:
Synthetic Communications. 30:4513-4521
Naloxone 3-methyl ether was selectively oxidized by treatment with cerium ammonium nitrate in aqueous acetonitrile at ambient temperature to provide the 10-(S)-hydroxy adduct. The stereochemistry of the oxidation product was proven by single crystal
Autor:
Gary Avonn Cain
Publikováno v:
Organic Preparations and Procedures International. 32:88-91
(2000). AN IMPROVED SYNTHESIS OF 3-CYANO-4-FLUOROBENZYL BROMIDE. Organic Preparations and Procedures International: Vol. 32, No. 1, pp. 88-91.
Autor:
Gary A. Cain, Christopher A. Teleha
Publikováno v:
Organic Preparations and Procedures International. 32:96-99
(2000). A CONVENIENT SYNTHESIS OF N-Boc-4-FORMYLPIPERINE. Organic Preparations and Procedures International: Vol. 32, No. 1, pp. 96-99.
Autor:
Patricia P Harlow, Susan M. Spitz, Mark S. Forsythe, Ruth R. Wexler, Martha H. Corjay, Joseph J. Petraitis, Peter J. Bouchard, Gregory C. Houghton, Shaker A. Mousa, Prabhakar K. Jadhav, Frank A. Barbera, Douglas G. Batt, Dilip P. Modi, Gary A. Cain
Publikováno v:
Journal of Medicinal Chemistry. 43:41-58
A new series of indazole-containing αvβ3 integrin antagonists is described. Starting with lead compound 18a, variations in a number of structural features were explored with respect to inhibition of the binding of β3-transfected 293 cells to fibri
Autor:
Chu-Biao Xue, John Wityak, Thais M. Sielecki, Donald J. Pinto, Douglas G. Batt, Gary A. Cain, Michael Sworin, Arlene L. Rockwell, John J. Roderick, Shuaige Wang, Michael J. Orwat, William E. Frietze, Lori L. Bostrom, Jie Liu, C. Anne Higley, F. Wayne Rankin, A. Ewa Tobin, George Emmett, George K. Lalka, Jean Y. Sze, Susan V. Di Meo, Shaker A. Mousa, Martin J. Thoolen, Adrienne L. Racanelli, Elizabeth A. Hausner, Thomas M. Reilly, William F. DeGrado, Ruth R. Wexler, Richard E. Olson
Publikováno v:
Journal of Medicinal Chemistry. 40:2064-2084
Using isoxazoline XR299 (1a) as a starting point for the design of highly potent, long-duration GPIIb/IIIa antagonists, the effect of placing lipophilic substituents at positions alpha and beta to the carboxylate moiety was evaluated. Of the compound
Publikováno v:
Biochemistry. 35:1270-1273
The active metabolite of leflunomide. A771726, is a novel immunosuppressive compound that has been shown to be a powerful antiproliferative agent for mononuclear and T-cells. The molecular mechanism of action for this compound has not been clearly es